We use cookies to offer you the best experience on our website. Learn more about the cookies we use and how you can manage them. Please review our information access procedures and our Privacy Statement. By clicking the "X" to remove this notice and/or continuing without changing your settings, you agree to our use of cookies.

  • 1 800 260 6682

  • GTranslate

Live in Nova Scotia
The Labs
The Labs

The Labs is more than just space and infrastructure. It’s a community.
« Back
Export from Nova Scotia
Export Development Program
Export Development Program

The Export Development Program supports businesses to increase sales outside of Nova Scotia and improve competitiveness.
« Back
Invest in Nova Scotia
Business Development Incentives
Business Development Incentives

Expanding a business? We have incentives and competitive costs to meet your needs.
« Back
Do Business in Nova Scotia
Business Licenses & Permits
Business Licenses & Permits

Find information on starting and operating a business in Nova Scotia at the Access Nova Scotia website. Take a look.
« Back

Other ways to reach us: 1.800.260.6682 | 902.424.8670 | info@investnovascotia.ca

  • Home
  • Articles
  • Appili Therapeutics to Commence Trading on Main Board of the TSX Exchange

Appili Therapeutics to Commence Trading on Main Board of the TSX Exchange

Monday, September 14, 2020

Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the Company or Appili), a biopharmaceutical company developing anti-infective drug candidates, today announced that its common shares will commence trading on the Toronto Stock Exchange (TSX) as of the opening of trading on Wednesday, September 16, 2020, under the Company's current trading symbol, "APLI."

Read the new release.

Appili Therapeutics is an Innovacorp portfolio company.

Halifax, Nova Scotia, September 14, 2020

Categories

Start-up

Invest Nova Scotia © 2024